Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2K146
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda
S2X324
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2N28
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2X259
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
CV30
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
VHH-72-Fc